New horizons in immunotherapy

CELL AND GENE THERAPY INSIGHTS

August 2023

New horizons in immunotherapy

Download PDF

Editorial

European research infrastructures join forces to provide innovative cancer research services across Europe—how can they support the cell and gene therapy developer?

European research infrastructures join forces to provide innovative cancer research services across Europe—how can they support the cell and gene therapy developer?

E Oldoni, P Carvajal-Vallejos, F Bietrix et al.

Expert Insight

Harnessing chimeric antigen receptor (CAR)-T cells as a potential treatment for Alzheimer’s disease

Harnessing chimeric antigen receptor (CAR)-T cells as a potential treatment for Alzheimer’s disease

Lauren Sarko, Krishanu Saha

14 September 2023

Interview

Developing universal AAV immuno-gene therapy for oncology

Developing universal AAV immuno-gene therapy for oncology

Does synthetic biology hold the key to unlocking solid tumors for cell and gene therapy?

Does synthetic biology hold the key to unlocking solid tumors for cell and gene therapy?

Rearming the immune system with personalized allogeneic CAR-T cell therapy

Rearming the immune system with personalized allogeneic CAR-T cell therapy

Increasing patient access to cellular immunotherapy through RNA gene writing

Increasing patient access to cellular immunotherapy through RNA gene writing

Madhusudan Peshwa

Viewpoint

iNKT cells for allogeneic cell therapy

iNKT cells for allogeneic cell therapy

Eleni Chantzoura, Paul Ibbett

Webinars

Expand your T cell manufacturing capacities in an automated, closed system to shorten your production time

Expand your T cell manufacturing capacities in an automated, closed system to shorten your production time

Sophia Lollies, Ian Johnston